Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week.

Tegeler, J; Lehmann, E; Weiher, A; Heinrich, K

Tegeler, J; Lehmann, E; Weiher, A; Heinrich, K.

Affiliation

Tegeler J; Department of Psychiatry, University of Duesseldorf, FRG.

Pharmacopsychiatry ; 23(6): 259-64, 1990 Nov.

Article in En | MEDLINE | ID: mdl-2284327

Subject(s)

Dyskinesia, Drug-Induced/epidemiology; Fluspirilene/administration & dosage; Akathisia, Drug-Induced; Anxiety Disorders/drug therapy; Benzodiazepines/administration & dosage; Benzodiazepines/adverse effects; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced/diagnosis; Dyskinesia, Drug-Induced/etiology; Female; Fluspirilene/adverse effects; Humans; Male; Middle Aged; Neurotic Disorders/drug therapy; Parkinson Disease, Secondary/chemically induced; Parkinson Disease, Secondary/diagnosis; Physical Examination; Prevalence; Psychomotor Agitation/diagnosis; Psychophysiologic Disorders/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dyskinesia, Drug-Induced / Fluspirilene Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Pharmacopsychiatry Year: 1990 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links